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Background: Disseminated intravascular coagulation (DIC) is an acquired disorder characterized by the activation of
intravascular coagulation and excessive fibrin formation. It always occurs in association with other clinical
conditions, including parasitic diseases. DIC has been described as a unusual complication in human and canine
visceral leishmaniasis.
Case presentation: DIC was found in a seven-year-old male mongrel dog naturally infected by Leishmania
(Leishmania) chagasi. Haemostasis parameters demonstrated changes in primary and secondary haemostasis and
fibrinolysis.
Conclusion: DIC is a unusual condition described in canine visceral leishmaniasis and it seems to be associated
with several immunological and pathological mechanisms involved in the disease.
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Disseminated intravascular coagulation (DIC) is a syn-
drome characterized by the systemic activation of blood
coagulation which generates intravascular fibrin leading
to thrombosis in small and medium sized vessels and
eventually organ dysfunction [1]. It can be also associ-
ated with severe hemorrhaging due to the consumption
of platelets and coagulation factors [2]. DIC is not a pri-
mary disorder, always occurring in association with other
clinical conditions, including sepsis, trauma, pregnancy
complications, intravascular hemolysis, neoplasias, toxi-
city, hepatic diseases, cardiovascular diseases, parasitic
diseases (protozoa) and others [3]. In human visceral
leishmaniasis, DIC has been reported as an unusual
complication [4]. In a review of hematological manifesta-
tions of visceral leishmaniasis, four human patients were* Correspondence: carlahonse@yahoo.com.br
†Equal contributors
1Laboratório de Pesquisa Clínica em Dermatozoonoses em Animais
Domésticos, Instituto de Pesquisa Clínica Evandro Chagas, Fundação
Oswaldo Cruz (Fiocruz), Av. Brasil, 4365, Manguinhos, Rio de Janeiro
21045-900, Brasil
Full list of author information is available at the end of the article
© 2013 Honse et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orassociated with disseminated intravascular coagulopathy
[5]. Blount et al. suggested that circulating immuno-
complexes can directly activate the coagulation cascade
in this disease [6].
The scarcity of publications regarding this disorder in
canine visceral leishmaniasis [7,8] and the complex patho-
genesis of both diseases, in which the liberation of inflam-
matory cytokines play important role in the response of
host, motivated us to describe this clinical report of dis-
seminated intravascular coagulation in a dog naturally
infected by Leishmania (Leishmania) chagasi from Rio de
Janeiro – Brazil.Case presentation
A seven-year-old male mongrel dog, weighing 10 kg,
was taken to the Laboratory of Clinical Research on
Dermatozoonosis in Domestic Animals, Evandro Chagas
Clinical Research Institute – Oswaldo Cruz Foundation
(Fiocruz), with a clinical suspicion of visceral leishmania-
sis by Secretaria Municipal de Saúde do Rio de Janeiro
(Municipal Health Department of Rio de Janeiro). The
clinical examination revealed the presence of a singleLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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measuring 0.5 cm in diameter, in the left ear, emaciation
and lethargy. The mucous membranes were pale and the
animal had signs of hepatomegaly and splenomegaly.
There was no evidence of epistaxis, and the rectal
temperature was 38.8°C.
Bleeding time (BT) was assessed with an automated
spring-loaded device (2.4 mm - Unistik 2 Normal,
Owem Mumford) in dry, clean and hairless skin of the
inner right ear. Blood from the incision was blotted with
Whatman nº2 filter paper every thirty seconds untill all
bleeding stopped [9,10]. BT was 600 seconds (reference
value 138 seconds).
Blood samples were collected by cephalic venipuncture
and placed in three sets of tubes, one without anticoagu-
lant for serological reassessment (Indirect ImmunoFluo-
rescence – IIF), another with ethylenediaminetetraacetic
acid (10 percent) for hematological evaluation and the
third with sodium citrate (3.2 per cent) for coagulation
tests. The serum sample was tested for anti-Leishmania
antibodies with the IFI-Leishmaniose-Visceral-Canina-
Bio-Manguinhos test (Bio-Manguinhos, Rio de Janeiro,
Brazil) and the dog was seroreactive with titer ≥ 1/160.
According to standards established by Ministério da Saúde
(Health Department) [11], this canine patient was hu-
manely euthanized with an intravenous administration of
sodium thiopental 5%. After euthanasia, cutaneous lesion
and spleen fragments were collected and immersed in sa-
line containing 100 μg of 5’fluorocytocine, 1000 IU of
penicillin and 200 μg of streptomycin per milliliter and
stored at 4°C for 24 h. Afterwards, the fragments were
transferred aseptically to a biphasic culture medium
(NNN supplemented Schneider’s medium with 10% fetal
bovine serum) and stored at 26–28°C. The fresh culture
was monitored weekly for thirty days. Multi-locus enzyme
electrophoresis (MLEE) was adopted for characterization
of isolates, in accordance with Cupolillo et al. [12]. The
parasite was isolated and, after isoenzyme analysis, was
identified as Leishmania (Leishmania) chagasi.
The serum sample was also tested for the Dirofilaria
immitis antigen as well as the antibodies against Borrelia
burgdorferi and Ehrlichia canis (SNAP 3Dx – IDEXX),
the results being negative.
Complete blood count (CBC) was performed with an
automated cell counter (Coulter Model T-890) and the
blood smears were stained by the Romanowsky method
with Giemsa stain (Giemsa Stain Modified, Sigma-Aldrich
). Hematological findings included PCV 26% (reference
value 46%), RBC 3.6x106/μL (reference value 6.5x106/μL),
hemoglobin 8.4 g/dL (reference value 15.4 g/dL), platelets
128x103/μL (reference value 273×103/μL) and total plas-
matic protein 9.0 g/dL (reference value 7.1 g/dL).
Prothrombin time (PT) (ThromborelW S, Dade Behring)
and activated partial thromboplastin time (APTT)(Pathromtin SL, Dade Behring) were determined with a
fully-automated coagulation system – Sysmex Serie CA –
500 (Sysmex America, Inc.). A group of healthy dogs
(n=18) was recruited for reference values of the he-
mostasis parameters. The animals, clinically and labora-
tory healthy (data not shown), were serologically negative
for the Dirofilaria immitis antigen as well as antibodies
against Borrelia burgdorferi and Ehrlichia canis (SNAP
3Dx – IDEXX) and not reactive to Leishmania sp. by the
IIF test (Bio-Manguinhos, Rio de Janeiro, Brazil). PT and
APTT were considered prolonged when the subject’s time
was at least 30% longer than the healthy control’s time [2].
Hemostatic abnormalities included prolonged activated
partial thromboplastin time 128.0 seconds (reference value,
37.2 seconds) and prolonged prothrombin time 9.8 seconds
(reference value, 7.3 seconds).
The DadeW DIMERTEST latex assay was adopted for
the rapid qualitative evaluation of circulating derivatives
of fibrin degradation products (XL-FDP) (Dade Behring).
The result was positive with sample agglutination.
Discussion
Disseminated intravascular coagulation (DIC) is a
hematological syndrome characterized by the activation of
intravascular coagulation resulting in excessive fibrin for-
mation and simultaneous consumption of coagulation fac-
tors and platelets resulting in severe hemorrhaging. DIC
can be either acute (decompensated) or chronic (compen-
sated) [13]. In general, several simultaneously occurring
mechanisms play a role in the pathogenesis of disease. Fi-
brin deposition is a result of tissue factor/FVIIa complex-
mediated thrombin generation and dysfunctional physio-
logical anticoagulant pathways (mainly antithrombin III
and protein C) [14]. A third important inhibitor of coagu-
lation is tissue factor pathway inhibitor (TFPI), although
its role in the pathogenesis of DIC is not clear. In addition,
the inhibition of fibrinolytic activity by increased plasma
levels of plasminogen activator inhibitor type 1 (PAI-1)
results in a inadequate removal of fibrin contributing to
thrombosis in small and medium sized vessels [14]. The
activation and liberation of inflammatory cytokines in
pathogenesis of DIC is unquestionable. According to van
der Poll et al. [15], coagulation proteins (FXa, thrombin
and Fibrin) can activate endothelial cells, stimulating the
synthesis of proinflammatory cytokines and growth factor.
Several clinical conditions may lead to the develop-
ment of DIC, including parasitic diseases. Activation of
coagulation and subsequent fibrin deposition are essen-
tial parts of the host defense against infectious agents in
an attempt to contain the invading microorganisms and
the subsequent inflammatory response [1]. However, an
exaggerated response can lead to a situation in which
coagulation itself contributes to its most severe form of
Honse et al. BMC Veterinary Research 2013, 9:43 Page 3 of 5
http://www.biomedcentral.com/1746-6148/9/43the disease causing microvascular thrombosis, organ
dysfunction and bleeding [16]. Clinical signs such as epi-
staxis [17–19], haematuria [18,20] and disseminated
intravascular coagulation [7] as well as laboratory abnor-
malities in haemostasis [7,8,21] have been reported in
dogs with canine visceral leishmaniasis, suggesting that
this protozoan affects not only primary and secondary
haemostasis but fibrinolysis as well. In this report, the
dog did not present clinical evidence of haemostatic ab-
normalities. This can be explained by a balance between
destruction and production of coagulation factors and
platelets resulting in a chronic or compensated status.
The pathophysiology of compensated DIC and decom-
pensated DIC is fundamentally the same, but acute DIC
results from generation of a large amount of thrombin
in a brief time period leading to hypercoagulable state
and thrombosis, that can be followed by the develop-
ment of a so-called hypocoagulable phase caused by de-
pletion of clotting factors leading to bleeding, while the
chronic DIC results of exposure of the coagulation system
to small amounts of tissue factor, in which the coagulation
factors and platelets are more able to be replaced in the
majority of patients [13].
Hepatomegaly, splenomegaly and nephropathy have
been often reported in dogs with canine visceral leishman-
iasis [22,23]. Leishmania organisms can infect many dif-
ferent types of cells, including those of the mononuclear
phagocityc system (macrophages and Kupffer cells), endo-
thelial cells, hepatocytes, dendritic cells and others [24,25].
Activated mononuclear cells and endothelial cells induce
expression of tissue factor that activates platelets and the
coagulation system. Hepatomegaly is the result of infla-
mmatory cell infiltration, permanent cell hypertrophy/
hyperplasia and possible passive congestion [23,26]. Chro-
nic granulomatous inflammation may be initially re-
stricted within sinusoids and then expand to involve
portal area, capsule or become diffuse [27,28], resulting in
coagulation factor deficiency. Splenomegaly is caused by
proliferation and/or infiltration of immune cells and is as-
sociated to hyperplasia of white and red pulp by changes
in microvascular structure [29]. Spleen has been proposed
as a key organ to allow long-term parasite survival due to
an ineffective immune response and it has been correlated
with the number of macrophages expressing complement
receptors [30]. Nephropathy, which has been associated to
immune-mediated mechanims, is characterized by pre-
sence of membranoproliferative glomerulonephritis and
tubulointerstitial nephritis (rarely amyloidosis) [31] that
can enable the loss of antithrombin III, a potent inhibitor
of serine proteases in the coagulation cascate, contributing
to the development of DIC. In the present case, clinical
signs of hepatomegaly and splenomegaly were observed,
but hepatic and renal enzymes and histopathological ana-
lysis were not performed.As mentioned before, DIC is not a disease in itself, but
always occurs secondary to an underlying disorder. Cli-
nical evidence of metabolic disease, co-infeccions such as
Babesia sp., neoplasias (e.g. lymphoma), immunological
reactions, toxic reactions or trauma were not observed in
the case reported here.
Previous studies on haemostasis in canine visceral
leishmaniasis have obtained different results, indicating
that many factors may play a role in the etiology of
hemorrhagic manifestations, such as epistaxis, associ-
ated with the disease. According to Font et al. [7],
epistaxis seems to be a result of inflammatory and
ulcerative lesions of the nasal mucosa rather than
changes in the clotting system. For Juttner et al. [32],
other haemostatic defects may also contribute to epi-
staxis in dogs with leishmaniasis, particularly in the
advanced stages of the disease. Petanides et al. [33] sug-
gest that a single pathogenic mechanism can not be
incriminated for epistaxis in natural canine visceral
leishmaniasis, but rather the interaction of various in-
ternal factors.
Bleeding time is a less sensitive in vivo test of platelet
function and its prolongation indicates platelet aggrega-
tion or adhesion defect. In this case, prolonged bleeding
time can be attributed to vascular damage and thrombo-
cytopenia. Domíngues and Torano [34] demonstrated
that in the initial phases of infeccion, the Leishmania
was able to interact directly with platelets by a specific
mechanism causing formation of large aggregates. High
concentrations of gammaglobulin may be associated
with circulating immune complexes, common in canine
visceral leishmaniasis [35,36], which may either be de-
posited on the vascular wall causing endothelial defects,
platelet-platelet interaction disturbances and/or inter-
action deficiency between the platelets and the damaged
subendothelium by coating the platelets and inhibiting
degranulation and/or adhesion according to Juttner et al.
[32]. Moreno et al. [17] reported an prolonged bleeding
time in the presence of a normal platelet count in dogs
with high plasma creatinine levels, attributing this fin-
ding to the platelet dysfunction associated with renal
failure.
Thrombocytopenia has been related in canine visceral
leishmaniasis [8,37,38] and ascribed to immune-mediated
destruction triggered by the presence of immune com-
plexes leading to the formation of anti-platelet antibodies,
vasculitis resulting in a decrease of platelets [2] and the
rapid consumption of platelets resulting from dissemi-
nated intravascular coagulation [7]. Unfortunately, it was
not possible to evidence that these factors influenced
thrombocytopenia developed by this dog, as well as hepa-
tomegaly and splenomegaly. In other studies [17,32], a
normal platelet count has been attributed in both stages
of the disease (acute and chronic).
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thromboplastin time and prothrombin time were appar-
ent. Prolonged PT can be explained by disseminated
intravascular coagulation with a reduction of the clotting
factors involved in extrinsic and common pathways.
Ciaramella et al. [19] observed normal PT values and at-
tributed this finding to either the low sensitivity of the
commercial PT tests on plasma canine or to a faster
consumption of one or more of the intrinsic pathway
clotting factors employed as activators in the formation
of inflammatory chemical mediators [39]. Moreno [21]
also declared normal m-OSPT (modified one-stage pro-
thrombin time) possibly explained by the different de-
gree of hepatic injury and the absence of disseminated
intravascular coagulation. Badylak et al. [40] have repor-
ted prolonged one-stage prothrombin time in dogs with
hepatic damage. In our case liver enzymes were not
measured. Prolonged APTT can be justified by dissemi-
nated intravascular coagulation with a reduction in clot-
ting factors involved in intrinsic and common pathways.
This finding can also be related to renal failure or to
liver disease, which may result in coagulation factor defi-
ciency impairing the synthesis, although renal and liver
enzymes were not measured in this case. Font et al. [7]
reported a prolonged APPT in a dog with visceral leish-
maniasis that had multiple hemorrhagic foci in the hepa-
tic parenchyma. Moreno [21] also described prolonged
APPT, even though bleeding was not always present.
Valladares et al. [8] observed normal PT and APPT
values in dogs with experimentally induced leishmania-
sis. According to Ruiz de Gopegui et al. [41], PT and
APTT within the reference interval may be seen appear
in patients with early and compensated DIC.
The presence of circulating derivatives of fibrin deg-
radation products can be linked to disseminated intra-
vascular coagulation in this dog. In canine leishmaniasis,
an increase in the concentration of fibrin degradation
products has also been reported and accounted to either
the renal loss of antithrombin III with a subsequent hy-
percoagulability state and increased fibrinolysis [42] or
disseminated intravascular coagulation [7,8]. Moreno et al.
[21] did not established differences in the levels of fibrin
degradation products in their study.
Conclusion
Several mechanisms can lead to activation of intravascular
coagulation, including endotheial damage, platelet activa-
tion and release of tissue procoagulants. In canine visceral
leishmaniasis, endotheial damage induced directly by
Leishmania and the deposition of immuncomplexes ap-
pear to play a role in triggering disseminated intravascular
coagulation. Thus, dogs naturally infected by Leishmania
(Leishmania) chagasi can develop disseminated intravas-
cular coagulation, which seems to be associated withseveral immunological and pathological mechanisms in-
volved in the disease.
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